- Stichting Katholieke Universiteit (Netherlands); - Academisch Ziekenhuis Groningen (Netherlands); - Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca (Spain); - Universidade do Porto (Portugal); - Enose B.V.(Netherlands); - Instituto Nacional de Enfermedades Respiratorias y del Ambiente – Ineram (Paraguay); - Universidad Nacional de Asuncion (Paraguay); - Task Foundation NPC (South Africa)
In 2016, the World Health Assembly launched the WHO’s ‘End TB strategy’; an ambitious project to reduce TB incidence by 90% before 2035 and progress to 1 TB case per million in 2050 worldwide. Effective routes to TB elimination are, among others, optimized treatment regimens to shorten treatment duration and better diagnostic methods. Unfortunately, advances are very slow due to a huge lack of funding and clinical research capacity to conduct trials. The TB research community needs to be both creative and innovative to build and strengthen existing capacity as well as to expand clinical trial networks to perform more cost- and time effective drug- and diagnostic trials.
With this RISE proposal we aim to strenghten the European-Latin American TB Research Collaboration Network (EUSATRCS), offer capacity building for Paraguayan and European TB professionals and build up a Latin American TB clinical hub.
A group of ESRs, ERs, TECH and other professionals are brought together to carry out clinical research spanning epidemiology of TB in populations to GWAS and the validation of an innovative eNose device for point-of-care diagnostic value.
The ISPUP website collects cookies considered essential for its functioning. In addition to these, if you allow it, for statistical purposes, we collect cookies about your visit. Read More
ISPUP embeds videos from its official YouTube channel on the website using YouTube's privacy mode. When clicking on the video, YouTube cookies may be stored. For more information read our privacy policy and Youtube privacy policy.
